Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Adult T-cell Leukemia/Lymphoma: early-phase trial registry
3 of 9 indexed Adult T-cell Leukemia/Lymphoma trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 3 currently recruiting · #1,916 of 28,707 conditions by registered trial count
Adult T-cell Leukemia/Lymphoma: 9 US clinical trials tracked, 3 recruiting.
Adult T-cell Leukemia/Lymphoma is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most active sponsor is Kyowa Kirin, running 1 of these trials.
Enrollment posture brief
Registry condition adult-t-cell-leukemialymphoma
OPEN 3 | RECR 33% | LATE 0 | EARLY 9 | RANK #1916 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Adult T-cell Leukemia/Lymphoma lists 3 open slots (33% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Adult T-cell Leukemia/Lymphoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Adult T-cell Leukemia/Lymphoma is recruiting below its size-band peers.
3 of 9 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Adult T-cell Leukemia/Lymphoma trials is spread across many organizations.
Kyowa Kirin accounts for 1 of 9 trials (11.1%). 9 distinct sponsors appear on at least one study for this condition label.
-
Most Adult T-cell Leukemia/Lymphoma trials plan to enrol fewer than 100 people.
Median target enrolment is 44 among the 9 trials that report a genuine target (sentinel values excluded). 8 of those (88.9%) plan for fewer than 100 participants.
-
Adult T-cell Leukemia/Lymphoma research is mostly interventional.
9 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
Two Step Haplo With Radiation Conditioning
Thomas Jefferson University
NCT05031897
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
Jonathan Brammer
NCT07356245
Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma
National Cancer Institute (NCI)
NCT07388563
Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01)
Daiichi Sankyo
NCT04703192
Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma
City of Hope Medical Center
NCT03113500
BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma
UNC Lineberger Comprehensive Cancer Center
NCT03264131
KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)
Kyowa Kirin
NCT01626664
A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
NCT01184885
Lenalidomide in HTLV-1 Adult T-Cell Leukemia
Columbia University
NCT01274533
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 7 |
Top Sponsors
Named interventions
Most-linked intervention names on Adult T-cell Leukemia/Lymphoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Adult T-cell Leukemia/Lymphoma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Adult T-cell Leukemia/Lymphoma page
9 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Adult T-cell Leukemia/Lymphoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Kyowa Kirin sponsors the most Adult T-cell Leukemia/Lymphoma trials on record, review their full trial history before evaluating a specific study. See Kyowa Kirin's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Adult T-cell Leukemia/Lymphoma condition card totals 9 registered trials; most-linked intervention Brentuximab Vedotin; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.